• Regulatory House

PRAC recommends the suspension of the MA for HES solutions for infusion in the EU

Based on the studies, that were conducted and in view of the serious risks that certain patient populations are still exposed to, EMA’s safety committee (PRAC) has recommended that marketing authorisations for hydroxyethyl-starch (HES) solutions for infusion should be suspended across the European Union (EU).


For more information see this link.


9 zobrazení

Nejnovější příspěvky

Zobrazit vše

Minulý týden proběhl tzv. evropský antibiotický den. Ten si klade za cíl jednak zvýšit povědomí o uvážlivém používání antibiotik a s ním spojené riziko resistence bakterií, ale také poskytuje platform

Through suggestions, but also through its own official activities, SÚKL has found that many health care facilities, especially through the Internet and social networks, significantly promote the admin